Suppr超能文献

乳房重建术后的瘢痕愈合:亚洲患者的5年随访

Scar Healing after Breast Reconstruction: A 5-year Follow-up in Asian Patients.

作者信息

Murakami Risa, Shiraishi Tomohiro, Imamura Mikiko, Takushima Akihiko, Suga Hirotaka

机构信息

Department of Plastic Surgery, Teikyo University School of Medicine, Mizonokuchi Hospital, Kanagawa, Japan.

Department of Plastic Surgery, Kyorin University School of Medicine, Tokyo, Japan.

出版信息

J Plast Reconstr Surg. 2024 Aug 23;4(1):20-25. doi: 10.53045/jprs.2024-0013. eCollection 2025 Jan 27.

Abstract

OBJECTIVES

Hypervascularity, hypertrophy, and hyperpigmentation of breast scars often persist for several years after reconstruction. There are few reports on the long-term follow-up of postoperative scars after breast reconstruction. We previously reported that at 1 year after reconstruction, >30% of Asian patients showed abnormal scars. In this study, we followed these patients for as long as 5 years postoperatively.

METHODS

We followed 101 Asian patients who underwent immediate two-stage implant-based breast reconstructions between 2013 and 2017 and still had abnormal scars involving hypervascularity, hypertrophy, or hyperpigmentation at 1 year postoperatively. We conducted annual follow-up for an additional 4 years, assessing the time until improvement and performing statistical analysis of factors related to the persistence and healing of abnormal scars.

RESULTS

Hypervascularity improved in 12%, 37%, 68%, and 82% of patients at 2, 3, 4, and 5 years, respectively. Most cases improved between 3 and 4 years postoperatively. Among the patients with both hypervascularity and hypertrophy at 1 year, 36% had residual hypervascularity at 5 years compared with 9.8% of those with hypervascularity only at 1 year. Hypertrophy improved within 5 years in 56% of the cases. Hyperpigmentation improved within 5 years in only 21% of the cases. There was no significant association between abnormal scars and age or body mass index.

CONCLUSIONS

Even in Asian patients with persistent hypervascularity of breast scars, most cases improve within 5 years after reconstruction. However, hypervascularity tends to persist in cases that also show hypertrophy. Compared with hypervascularity and hypertrophy, hyperpigmentation showed worse 5-year improvement.

摘要

目的

乳房瘢痕的血管增生、肥大及色素沉着在重建术后常持续数年。关于乳房重建术后瘢痕的长期随访报道较少。我们之前报道过,重建术后1年,超过30%的亚洲患者出现异常瘢痕。在本研究中,我们对这些患者进行了长达5年的术后随访。

方法

我们对2013年至2017年间接受即刻两阶段乳房假体植入重建且术后1年仍有涉及血管增生、肥大或色素沉着的异常瘢痕的101例亚洲患者进行了随访。我们又进行了4年的年度随访,评估瘢痕改善所需时间,并对与异常瘢痕持续存在及愈合相关的因素进行统计分析。

结果

血管增生分别在术后2年、3年、4年和5年改善的患者比例为12%、37%、68%和82%。大多数病例在术后3至4年改善。在术后1年既有血管增生又有肥大的患者中,5年时仍有36%存在残余血管增生,而术后1年仅有血管增生的患者这一比例为9.8%。56%的肥大病例在5年内得到改善。色素沉着在5年内仅21%的病例得到改善。异常瘢痕与年龄或体重指数之间无显著关联。

结论

即使是乳房瘢痕持续存在血管增生的亚洲患者,大多数病例在重建术后5年内也会改善。然而,在同时伴有肥大的病例中血管增生往往持续存在。与血管增生和肥大相比,色素沉着在5年时的改善情况较差。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d1b/11950569/d96167a74816/jprs-04-01-0020-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验